Safety and Immunogenicity Study of AERAS-456 Vaccine for Tuberculosis
NCT01967134
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
25
Enrollment
OTHER
Sponsor class
Conditions
Latent Tuberculosis
Latent Tuberculosis Bacteriology and Histology Unknown
Interventions
BIOLOGICAL:
H56:IC31
Sponsor
Aeras
Collaborators
[object Object]